AtriCure (ATRC) Tops Q3 EPS by 10c ; Offers Guidance
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $30.18 +7.29%
Revenue Growth %: +11.7%
Financial Fact:
Selling, general and administrative expenses: 25.49M
Today's EPS Names:
CGEH, NAKA, APOG, More
Revenue Growth %: +11.7%
Financial Fact:
Selling, general and administrative expenses: 25.49M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q3 EPS of ($0.01), $0.10 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $134.3 million versus the consensus estimate of $131.25 million.
GUIDANCE:
AtriCure sees FY2025 EPS of ($0.23)-($0.26), versus the consensus of ($0.36). AtriCure sees FY2025 revenue of $532-534 million, versus the consensus of $530.6 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gulfport Energy and Mobility Global to join S&P SmallCap 600
- Deutsche Bank Upgrades Softbank Group Corp. (9984:JP) (SFTBY) to Buy
- Select Medical stockholders approve buyout by insider-led consortium
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
